Trial | NCT04651023  Report issue

Title

Shanghai Meiji Health Science and Technology Co., Ltd

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    95
Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity. Ninety-five participants (23
Study Started
Jan 10
2009
Primary Completion
May 15
2009
Study Completion
Jun 20
2009
Last Update
Dec 03
2020

Dietary Supplement Nelumbo nucifera Leaf Extract

Hot water extracted Nelumbo nucifera Leaf, mainly containing quercetin and quercetin 3-O-glucuronide.

control group Placebo Comparator

During the 12-week study period, the participants consumed two bottles (2 *200 mL) of the experimental beverage (0g NnEx) per day with or after meals.

low concentration of NnEx group Experimental

During the 12-week study period, the participants consumed two bottles (2 *200 mL) of the experimental beverage (1g NnEx) per day with or after meals.

high concentration of NnEx group Experimental

During the 12-week study period, the participants consumed two bottles (2 *200 mL) of the experimental beverage (2g NnEx) per day with or after meals.

Criteria 

Inclusion Criteria:

Has a body mass index (BMI) of 23-30 kg/m2
Has no history of using any antidiabetic medication
Absence of liver, kidney, or heart disease
Absence of food allergy and daily tea consumption <2 L
Meet all of the above criteria and to follow the instructions given during the study.

Exclusion Criteria:

Testing delayed for >1 week without justification
Difficulty attending the hospital on the required days
Lack of data regarding the times of beverage consumption for over 5% of the study
Abnormal overeating
Test results believed to be unreliable because of the lack of provision of diet and exercise reports during the fasting period
Difficulty drawing blood
Poor confidence in the test data
No Results Posted